Discontinued — last reported Q4 '21
Geographic · D&A
Americas Orthopedics — D&A
Zimmer Biomet Holdings Americas Orthopedics — D&A remained flat by 0.0% to $35.78M in Q4 2021 compared to the prior quarter.
Analysis
StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2019
Last reportedQ4 2021Feb 25, 2022
Rolls up toD&A
How to read this metric
An increase often reflects recent capital investments in manufacturing or R&D, while a decrease may suggest aging assets or reduced investment in the segment's infrastructure.
Detailed definition
This represents the non-cash allocation of the cost of tangible assets and the systematic write-off of intangible assets...
Peer comparison
Standard across all capital-intensive manufacturing industries; comparable to segment-level D&A in medical device peers.
Metric ID:
zbh_segment_americas_orthopedics_depreciation_and_amortizationHistorical Data
1 years
| FY'21 | |
|---|---|
| Value | $143.1M |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Zimmer Biomet Holdings's americas orthopedics — d&a?
- Zimmer Biomet Holdings (ZBH) reported americas orthopedics — d&a of $35.78M in Q4 2021.
- What does americas orthopedics — d&a mean?
- The portion of asset costs recognized as an expense for the Americas Orthopedics segment during the period.